|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/7088 | (2006.01) |
| (11) | Number of the document | 3276004 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17190227.3 |
| Date of filing the European patent application | 2010-06-07 | |
| (97) | Date of publication of the European application | 2018-01-31 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 184937 P | 2009-06-08 | US | |
| 235381 P | 2009-08-20 | US |
| (72) |
FEINSTEIN, Elena, IL
ADAMSKY, Svetlana, IL
ERLICH, Shai, US
MOLITORIS, Bruce, US
|
| (73) |
The United States of America, as Represented by the Department of Veterans Affairs,
810 Vermont Avenue, NW, Washington, D.C. 20420,
US
Quark Pharmaceuticals, Inc., 7999 Gateway Boulevard, Suite 310, Newark, CA 94560, US |
| (54) | METHODS FOR TREATING CHRONIC KIDNEY DISEASE |
| METHODS FOR TREATING CHRONIC KIDNEY DISEASE |